• Treat 13F holdings as research leads, not buy signals: reported positions may omit private investments and other strategies, while fund AUM figures are estimates.
• For semiconductor research, compare TSM, LRCX, MU, and NVDA, which appear across multiple funds’ reported holdings; the discussion provides no price targets or explicit recommendations.
• No specific trade is supported by the rate, Anthropic, or INO mentions, which lack clear context or an actionable thesis.

Hedge-fund positioning and 13F research

• The speaker describes a new Godel feature that ranks hedge funds using their 13F holdings and estimated AUM. They call D.E. Shaw the world’s largest hedge fund “right now.”
• The AUM figures are the speaker’s own estimates, not necessarily reported fee-paying assets. They specifically say it is unclear whether all of Bridgewater’s roughly $100 billion is fee-paying AUM.
• Other funds named include Millennium, Elliott, TCI (Children’s Investment Fund), Two Sigma (about $80 billion), Citadel (about $77 billion), and Coatue (about $73 billion).
• The speaker notes that public holdings may not show a fund’s full activity: Elliott also does merger arbitrage and private equity, and the speaker wonders whether some of its holdings are filed elsewhere.

Takeaways

• The fund rankings and holdings may be useful for generating research ideas, but the AUM numbers are explicitly described as estimates.
• Don’t treat a 13F list as a complete picture of a fund’s strategy or as an automatic buy signal. The discussion itself highlights uncertainty around AUM and holdings outside public-stock portfolios.

Semiconductor and AI-related equities

• Taiwan Semiconductor Manufacturing (TSM), Lam Research (LRCX), and Micron (MU) are named among Coatue’s holdings.
• Tiger is described as holding TSM, Amazon (AMZN), NVIDIA (NVDA), Alphabet (GOOGL/GOOG), Meta Platforms (META), and LRCX. The speaker remarks that “everyone loves LAM” (Lam Research).
• Adage’s holdings include NVDA, Broadcom (AVGO), Micron (MU), and Advanced Micro Devices (AMD) is notably absent from the list, according to the speaker. They also point out that Lam Research is a large position.
• Applied Materials (AMAT) is mentioned, but the surrounding holdings list is garbled, so the transcript does not make its fund attribution clear.

Takeaways

• The discussion points to repeated hedge-fund interest in semiconductors, particularly TSMC, Lam Research, Micron, and NVIDIA.
• The speaker calls Adage’s portfolio “pretty indexy” and notes that AMD is absent from the holdings list being discussed. These are observations about the reported positions, not explicit recommendations.

Large-cap technology and internet equities

• Adage’s listed positions include Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet (GOOGL/GOOG), Meta (META), and Tesla (TSLA).
• Tiger is also described as holding Amazon, Alphabet, and Meta.
• Alphabet appears among the holdings attributed to the Children’s Investment Fund as well.

Takeaways

• Several funds named in the episode hold overlapping large technology companies. That overlap can be a useful starting point for further research, but the transcript gives no price targets or buy/sell recommendations.

Other publicly traded companies mentioned

• Children’s Investment Fund (TCI) is described as holding positions including GE Aerospace (GE), Visa (V), Moody’s (MCO), S&P Global (SPGI), Canadian Pacific Kansas City (CP), Canadian National Railway (CNI), Martin Marietta Materials (MLM), and Vulcan Materials (VMC). The transcript also names Alphabet and what sounds like Ferrovial; the list is somewhat garbled.
• Adage’s listed holdings also include Eli Lilly (LLY), Berkshire Hathaway (BRK.B), and JPMorgan Chase (JPM).
• Elliott’s holdings include Triple Flag Precious Metals (TFPM), Phillips 66 (PSX), Suncor Energy (SU), and HP (HPQ). The speaker says Elliott appears to own virtually all of Triple Flag, but the transcript does not provide more detail about that position.

Takeaways

• The funds’ reported holdings span financial data, industrials, transportation, materials, energy, and consumer-facing businesses.
• The speaker describes TCI’s portfolio as having only a handful of positions and calls it interesting, but does not give a specific view on the individual stocks.

SpaceX and Instacart

• The speaker says D1 Capital has a $21 billion position in SpaceX and that its next-largest position is Instacart, at $1 billion. The transcript does not explain how those positions are held or valued.
• The speaker says the Instacart investment “worked out pretty well,” but gives no return figures or timing.

Takeaways

• These are notable private-company exposures mentioned in the discussion, not recommendations or necessarily opportunities available to public-market investors.
• The transcript provides no valuation analysis, price target, or investment terms for either company.

Interest rates and yield curves

• The speaker mentions a Godel feature called WORP (World Interest Rate Probabilities), intended to show interest-rate probabilities.
• They read it as showing a 76% probability of a rate hike at the December meeting, but say they are unsure how to interpret the figure. No year is specified.
• The episode also mentions yield-curve tools for viewing whether curves have flattened or steepened.

Takeaways

• The transcript highlights tools for monitoring rate expectations and yield-curve changes, but the speaker explicitly expresses uncertainty about interpreting the probability figure.
• No rate forecast, policy recommendation, or investment action is stated.

Anthropic

• The speaker says Anthropic’s third-quarter results are out and mentions revenue of 16.9, but the transcript does not specify the unit or provide further context.

Takeaways

• The revenue figure is too incomplete to support a comparison or investment conclusion; confirm the unit and source before using it.

Inovio Pharmaceuticals (INO)

• Inovio is mentioned briefly: the speaker says its drug is “kind of well known,” without identifying the drug or discussing clinical, financial, or market details.

Takeaways

• The transcript offers no substantive investment thesis, recommendation, or risk assessment for Inovio.